首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Another Step Toward Standardization of Methods for Measuring Hemoglobin A1c
【24h】

Another Step Toward Standardization of Methods for Measuring Hemoglobin A1c

机译:迈向测量血红蛋白A1c方法标准化的又一步

获取原文
           

摘要

In this issue, Kobold et al. describe an exciting new Reference Method for hemoglobin A1c developed by the International Federation of Clinical Chemistry Working Group on Hemoglobin A1c (1). To our knowledge, this method represents the first time mass spectrometry has been applied to a protein of clinical interest in a high-level (Definitive) Reference Method. Measurements of hemoglobin A1c (or, alternatively, of glycohemoglobin) are increasingly important in the monitoring of glucose control in patients with diabetes. The test’s importance became especially prominent after the publication of the Diabetes Control and Complications Trial (DCCT), which demonstrated the importance of control of blood glucose in the prevention or delay of the complications of diabetes (2). The test has recently caught the eye of the US government as one that is underutilized (3). Thus, it is not much surprise that both an AACC Subcommittee, which has evolved into the National Glycohemoglobin Standardization Program (NGSP) (4), and an IFCC Working Group, from which Kobold’s report emanates, have been addressing glycohemoglobin standardization over the past several years.Several other editorials in this Journal (5)(6)(7) have commented on important papers relating to glycohemoglobin over the years. Because the most recent of these, one by Miedema, gave such a good overview of the chemistry of glucose addition to hemoglobin, nomenclature, and analytical methodologies, we will not repeat this information here. Instead, our discussion will focus on the relative importance of accurate results, harmonious results, and the preservation of reference values with which clinicians are familiar.The application of knowledge gained in any large clinical research study to routine medical practice is frequently a challenge. Of particular interest to clinical laboratorians are studies in which major therapeutic decisions are based on a clinical laboratory result. The scale used to measure the …
机译:在这个问题上,Kobold等。描述了由国际临床化学协会血红蛋白A1c工作组开发的激动人心的血红蛋白A1c新参考方法(1)。据我们所知,这种方法代表了质谱首次以高水平(确定性)参考方法应用于具有临床意义的蛋白质。血红蛋白A1c(或糖血红蛋白)的测量在监测糖尿病患者的血糖控制中越来越重要。该测试的重要性在《糖尿病控制与并发症试验》(DCCT)发布后显得尤为突出,该试验证明了控制血糖对预防或延缓糖尿病并发症的重要性(2)。这项测试最近未引起美国政府的关注,因为它没有得到充分利用(3)。因此,毫不奇怪的是,已经发展成为国家糖化血红蛋白标准化计划(NGSP)的AACC小组委员会(4),以及Kobold的报告所产生的IFCC工作组,在过去的数年中一直致力于糖化血红蛋白的标准化工作。多年来,本杂志(5)(6)(7)上的其他几篇社论都评论了与糖化血红蛋白有关的重要论文。因为最近的一本书(由Miedema撰写)很好地概述了除血红蛋白,命名法和分析方法外的葡萄糖化学方法,因此在此不再赘述。相反,我们的讨论将集中在准确结果,和谐结果以及保存临床医生熟悉的参考值的相对重要性上。在大型临床研究中获得的知识在常规医学实践中的应用通常是一个挑战。临床实验室医师特别感兴趣的是其中主要治疗决策基于临床实验室结果的研究。用于测量…的标度

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号